Please share the announcement.
Official Statement Regarding Recent Janoshik Testing Report Issues
To Our Valued Customers and Partners,
During recent purity testing conducted by Janoshik Analytical on select peptide products, we identified several concerning irregularities. In keeping with our commitment to transparency and accountability, we are issuing this public statement and taking appropriate corrective actions.
#### 1. Testing Delays and Data Inaccuracies
- Unacceptable Processing Time: Reports were delayed up to two weeks post-sample delivery—far exceeding standard turnaround times.
- HPLC Purity Calculation Errors:
- After we flagged discrepancies, Janoshik corrected the data *without explaining the cause of the errors*.
- Critical Issue: An anomalous peak at 274 nm (inconsistent with peptide characteristics) was erroneously included in purity calculations, artificially deflating results.
#### 2. Contaminant Identification Concerns
- We paid $170 for GC-MS analysis to identify the unknown substance.
- Our independent testing confirmed the compound as CAS 99-93-4.
- Janoshik's amended report (issued two days later) identified it as p-Chlorocresol but failed to provide:
- Molecular weight verification
- Rationale for attributing the 274 nm peak to this compound
- Our Objections:
- p-Chlorocresol is **a toxic substance requiring government clearance for purchase**—our decade of industry expertise precludes its intentional use.
- Janoshik’s opaque methodology (updating reports without evidentiary support) violates professional standards.
#### 3. Product Safety & Customer Assurance
- Minimal Distribution: Only a small batch was released, as pre-shipment in-house purity/potency testing ensured compliance.
- Customers Receiving Product: No action is required—we assume full responsibility for resolution.
- Ongoing Dialogue with Janoshik: We demand:
- Complete analytical data (MW, 274 nm peak justification)
- Explanation for contaminant inclusion in purity calculations
- Clarification on testing delays
#### 4. Our Commitment
- Zero Tolerance for Harmful Additives: All processes adhere to industry benchmarks.
- Enhanced Transparency: Implementing third-party verification protocols to prevent recurrence.
We urge Janoshik to address these concerns promptly and uphold their professional obligations.
SRYlab
June 15, 2026
*(Key improvements for U.S. audience: Concise phrasing, active voice, emphasis on accountability, and logical flow aligning with Western business communication standards.)
